E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Down 0.32 (0.30%)
Intraday High$108.73
Intraday Low$107.51
Data as of 09/21/18 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast - Replay
Quest Diagnostics at the Morgan Stanley 16th Annual Global Healthcare Conference
09/12/18 at 10:30 a.m. ET
Quest Diagnostics at the Morgan Stanley 16th Annual Global Healthcare Conference
Wednesday, September 12, 2018 10:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Headlines More >
Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Sept. 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation i... 
Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent
- More than half of Americans tested misused their prescription drugs in 2017 - Among patients in general care, use of non-prescribed medications and illicit drugs declined, but is still prevalent - Among patients in treatment for substance use disorder (SUD), misuse of heroin and prescription fentanyl surged nearly 400 percent; among patients testing positive for heroin, the rate of mixing with fentanyl nearly doubled - Drug mixing is the most frequent form of misuse with one-in-five t... 
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived fr... 
Quest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index
SECAUCUS, N.J., Aug. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace health program among the best in the nation. The American Heart Association created the Index with its CEO Roundtable members, a leadership collaborative of more than ... 
Upcoming EventsMore >
There are currently no events scheduled.
Contact Us:
Shawn Bevec
Vice President Investor Relations

Company Calendar
September 2018?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.